| Host immunity to Cryptococcus neoformans S Rohatgi, L Pirofski Future microbiology 10 (4), 565-581, 2015 | 133 | 2015 |
| Fc gamma receptor 3A polymorphism and risk for HIV-associated cryptococcal disease S Rohatgi, S Gohil, MH Kuniholm, H Schultz, C Dufaud, KL Armour, ... MBio 4 (5), 10.1128/mbio. 00573-13, 2013 | 63 | 2013 |
| Systematic design and testing of nested (RT-) PCR primers for specific amplification of mouse rearranged/expressed immunoglobulin variable region genes from small number of B cells S Rohatgi, P Ganju, D Sehgal Journal of immunological methods 339 (2), 205-219, 2008 | 62 | 2008 |
| Molecular characterization of the early B cell response to pulmonary Cryptococcus neoformans infection S Rohatgi, L Pirofski The Journal of Immunology 189 (12), 5820-5830, 2012 | 44 | 2012 |
| Eliminating expression of erucic acid-encoding loci allows the identification of “hidden” QTL contributing to oil quality fractions and oil content in Brassica juncea (Indian … A Jagannath, YS Sodhi, V Gupta, A Mukhopadhyay, N Arumugam, I Singh, ... Theoretical and applied genetics 122, 1091-1103, 2011 | 33 | 2011 |
| Molecular dissection of antibody responses against pneumococcal surface protein A: evidence for diverse DH-less heavy chain gene usage and avidity maturation S Rohatgi, D Dutta, S Tahir, D Sehgal The Journal of Immunology 182 (9), 5570-5585, 2009 | 33 | 2009 |
| The Role of B-Cells and Antibodies against Candida Vaccine Antigens in Invasive Candidiasis M Shukla, P Chandley, S Rohatgi Vaccines 9 (10), 1159, 2021 | 30 | 2021 |
| Naïve B cells reduce fungal dissemination in Cryptococcus neoformans infected Rag1−/− mice C Dufaud, J Rivera, S Rohatgi, L Pirofski Virulence 9 (1), 173-184, 2018 | 28 | 2018 |
| Antibody and B cell subset perturbations in human immunodeficiency virus-uninfected patients with cryptococcosis S Rohatgi, A Nakouzi, LJ Carreño, M Slosar-Cheah, MH Kuniholm, ... Open forum infectious diseases 5 (1), ofx255, 2018 | 21 | 2018 |
| Synthesis of rifaximin loaded chitosan-alginate core-shell nanoparticles (Rif@ CS/Alg-NPs) for antibacterial applications D Kumar, S Kumar, S Kumar, S Rohatgi, PP Kundu International Journal of Biological Macromolecules 183, 962-971, 2021 | 20 | 2021 |
| Vaccination with Secreted Aspartyl Proteinase 2 Protein from Candida parapsilosis Can Enhance Survival of Mice during C. tropicalis-Mediated Systemic … M Shukla, S Rohatgi Infection and Immunity 88 (10), 10.1128/iai. 00312-20, 2020 | 20 | 2020 |
| COVID-19-Associated Mucormycosis: a matter of concern amid the SARS-CoV-2 Pandemic P Chandley, P Subba, S Rohatgi Vaccines 10 (8), 1266, 2022 | 13 | 2022 |
| Host-parasite interactions during Plasmodium infection: Implications for immunotherapies P Chandley, R Ranjan, S Kumar, S Rohatgi Frontiers in Immunology 13, 1091961, 2023 | 11 | 2023 |
| Synthesis of vildagliptin loaded acrylamide-g-psyllium/alginate-based core-shell nanoparticles for diabetes treatment D Kumar, A Gautam, S Rohatgi, PP Kundu International Journal of Biological Macromolecules 218, 82-93, 2022 | 10 | 2022 |
| Expression, Purification, and Refolding of Chikungunya Virus Full-Length Envelope E2 Protein along with B-Cell and T-Cell Epitope Analyses Using Immuno-Informatics Approaches M Shukla, P Chandley, S Tapryal, N Kumar, SP Mukherjee, S Rohatgi ACS omega 7 (4), 3491-3513, 2022 | 5 | 2022 |
| A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms P Chandley, P Subba, S Rohatgi JoVE (Journal of Visualized Experiments), e64425, 2022 | 4 | 2022 |
| An overview of anti-chikungunya antibody response in natural infection and vaccine-mediated immunity, including anti-CHIKV vaccine candidates and monoclonal antibodies … P Chandley, A Lukose, R Kumar, S Rohatgi The Microbe 1, 100018, 2023 | 3 | 2023 |
| Recent Advances in the Development of Monoclonal Antibodies and Next-Generation Antibodies R Singh, P Chandley, S Rohatgi ImmunoHorizons 7 (12), 886-897, 2023 | 2 | 2023 |
| Expression and Purification along with Evaluation of Serological Response and Diagnostic Potential of Recombinant Sap2 Protein from C. parapsilosis for Use in … M Shukla, P Chandley, H Kaur, AK Ghosh, SM Rudramurthy, S Rohatgi Journal of Fungi 7 (12), 999, 2021 | 2 | 2021 |
| Host immunity to Cryptococcus neoformans Soma S Rohatgi, L Pirofski Physiology & behavior 176 (3), 139-148, 2017 | 2 | 2017 |
Mark KuniholmUniversity at AlbanyVerified email at albany.edu
